776
21. Tonkiss J, Morris RGM, Rawlins JNP 1988 Intra-ventricular in- 40.
fusion of the NMDA antagonist AI'5 impairs performance on a nonspatial operant DRL task in the rat. Exp Brain Res 73:181-188
22. McCaslin PI', Morgan WW 1986 Continuously infused 2-amino- 7-phosphonoheptanoic acid antagonizes N-methyl-o-aspartate-in- 41.
duced elevations of cyclic GMP in vim in multiple brain areas and
chemically-induced seizure activity. Neuropharmacology 25:905- 42.
909
23. Gilbert ME 1988 The NMDA-receptor antagonist, MK801, suppresses limbic kindling and kindled seizures. Brain Res 463:90-99 43.
24. Sato K, Morimoto K, Hiramatsu M, Mori A, Otsuki S 1989 Effect
of a noncompetitive antagonist (MK-801) of NMDA receptors on
convulsions and brain amino acid level in El mice. Neurochem Res 44.
14:741-744
25. Teyler TJ, Vardaris RM, Lewis D, Rawitch AB 1980 Gonadal
steroids: effects on excitability of hippocampal pyramidal cells. 45.
Science 209:1017-1019
26. Smith SS, Waterhouse BD, Woodward DJ 1987 Sex steroid effects
on extrahypothalamic CNS. I. Estrogen augments neuronal respon- 46.
siveness to iontophoretically applied glutamate in the cerebellum.
Brain Res 422:40-51
27. Smith SS 1989 Estrogen administration increases neuronal re- sponses to excitatory amino acids as a long-term effect. Brain Res 47.
503:354-357
28. Smith SS 1991 The effects of estrogen and progesterone on GABA
and glutamate responses at extrahypothalamic sites. In: Costa E, 48.
Paul SM (eds) Neurosteroids and Brain Function. Thieme Medical
Publishers, New York, pp 87-94
29. Recasens M, Guiramand J, Vignes M 1991 The putative molecular 49.
mechanism(s) responsible for the enhanced inositol phosphate synthesis by excitatory amino acids: an overview. Neurochem Res
16:659-668
30. Cunningham MD, Michaelis EK 1990 Solubilization and partial 50.
purification of 3-((+)-2-carboxypiperizine-4-yl)-[1,2-3H]propyl-l- phosphonic acid recognition proteins from rat brain synaptic membranes J Biol Chem 265:7768-7778 51.
31. Sills MA, Fagg G, Brundish DE, Hurt SD, Loo PS, Pozza M,
Wilusz EJ, Williams M 1991 [3H]CGP 39653: a new N-methyl-o- aspartate antagonist radioligand with low nanomolar affinity in rat 52.
brain. Eur J Pharmacol 192:19-24
32. Reynolds IJ, Murphy SN, Miller RJ 1987 3H-labeled MK-801
binding to the excitatory amino acid receptor complex from rat brain 53.
is enhanced by glycine. Proc Nat1 Acad Sci USA 84:7744-7748
33. Monaehan DT, Olverman HI, Neuven L, Watkins IC, Cotman
CW I‚Äù988 Two' classes of N-methyl&-aspartate recognition sites: 54.
differential distribution and differential regulation by glycine. Proc
Nat1 Acad Sci USA 85:9836-9840 55.
34. Wong EHF, Knight AR, Woodruff GN 1988 [3H]MK-801 labels a
site on the N-methyl-o-aspartate receptor channel complex in rat
brain membranes. J Neurochem 50:274-281
35. Niswender GD, Midgley Jr AR, Monroe SE, Reichert Jr LE 1968
Radioimmunoassay for rat luteinizing hormone with antiovine LH
serum and ovine LH-1311. Proc Sot Exp Biol Med 128:807-811 56.
36. Greenamyre JT, Olson JMM, Penney JB, Young AB 1985 Autoradiographic characterization of N-methyl-o-aspartate- quisqualateand kainate-sensitive glutamate binding sites. J Pharmacol Exp Ther
233~254-263 57.
37. Fagg GE, Olpe H-R, Pozza MF, Baud J, Steinmann M, Schmutz
M, Portet C, Baumann I', Thedinga K, Bittiger H, Allgeier H,
Heckendorn R, Angst C, Brundish D, Dingwall JG 1990 CGP 58.
37849 and CGP 39551: novel and potent competitive N-methyl-n- aspartate receptor antagonists with oral activity. Br J Pharmacol
99:791-797 59.
38. Kerwin R, Pate1 S, Meldrum B 1990 Quantitative autoradiographic
analysis of glutamate binding sites in the hippocampal formation in
normal and schizophrenic brain post mortem. Neuroscience 39:25- 60.
32
SAS Institute Inc 1982 SAS Users Guide: Statistics, ed 5. SAS
